COVID-19 associated mucormycosis - a recent challenge.
作者信息
Dos Santos Vitorino Modesto, Dos Santos Lister Arruda Modesto, Sugai Taciana Arruda Modesto
机构信息
Hospital das Forças Armadas (HFA), Department of Medicine, Brasília, DF, Brasil.
Universidade Católica de Brasília, Medical Course, Brasília, DF, Brasil.
出版信息
Autops Case Rep. 2023 Apr 13;13:e2023427. doi: 10.4322/acr.2023.427. eCollection 2023.
Abstract
摘要
相似文献
1
COVID-19 associated mucormycosis - a recent challenge.
Autops Case Rep. 2023 Apr 13;13:e2023427. doi: 10.4322/acr.2023.427. eCollection 2023.
2
A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
Ann Afr Med. 2022 Oct-Dec;21(4):383-389. doi: 10.4103/aam.aam_129_21.
3
COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.
Br J Oral Maxillofac Surg. 2021 Nov;59(9):1095-1098. doi: 10.1016/j.bjoms.2021.06.013. Epub 2021 Jun 29.
4
Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients.
Mol Biol Rep. 2022 Jun;49(6):4977-4988. doi: 10.1007/s11033-022-07160-3. Epub 2022 Feb 2.
5
Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital.
Med J Armed Forces India. 2021 Jul;77(Suppl 2):S289-S295. doi: 10.1016/j.mjafi.2021.06.009. Epub 2021 Jul 26.
6
COVID-19 Associated Mucormycosis (CAM): A Single Hospital-Based Study.
J Oral Maxillofac Pathol. 2022 Apr-Jun;26(2):147-155. doi: 10.4103/jomfp.jomfp_152_22. Epub 2022 Jun 28.
7
COVID-19 and mucormycosis superinfection: the perfect storm.
Infection. 2021 Oct;49(5):833-853. doi: 10.1007/s15010-021-01670-1. Epub 2021 Jul 24.
8
Using artificial intelligence-based models to predict the risk of mucormycosis among COVID-19 survivors: An experience from a public hospital in India.
J Infect. 2022 Mar;84(3):351-354. doi: 10.1016/j.jinf.2021.12.016. Epub 2021 Dec 23.
9
COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent.
Head Neck Pathol. 2022 Sep;16(3):645-650. doi: 10.1007/s12105-021-01382-w. Epub 2021 Nov 9.
10
Two Uncommon Presentations of COVID-19-Associated Mucormycosis.
Cureus. 2022 Jan 14;14(1):e21229. doi: 10.7759/cureus.21229. eCollection 2022 Jan.
本文引用的文献
1
Gastric mucormycosis.
Autops Case Rep. 2023 Feb 10;13:e2023421. doi: 10.4322/acr.2023.421. eCollection 2023.
2
Surge of mucormycosis during the COVID-19 pandemic.
Travel Med Infect Dis. 2023 Mar-Apr;52:102557. doi: 10.1016/j.tmaid.2023.102557. Epub 2023 Feb 20.
3
A Case of Gastric Mucormycosis in a 21-Year-Old Patient With Hemophagocytic Lymphohistiocytosis.
Cureus. 2022 Dec 5;14(12):e32215. doi: 10.7759/cureus.32215. eCollection 2022 Dec.
4
Pulmonary embolism and gastric bleed with disseminated mucormycosis - treading dangerous waters.
Monaldi Arch Chest Dis. 2022 Nov 25;93(3). doi: 10.4081/monaldi.2022.2418.
5
Primary gastric mucormycosis presenting with post-Coronavirus disease - 19 upper gastrointestinal bleed.
Indian J Gastroenterol. 2023 Oct;42(5):736-737. doi: 10.1007/s12664-022-01298-5.
6
Fatal invasive gastric mucormycosis: Two case reports.
Clin Case Rep. 2022 Sep 12;10(9):e6330. doi: 10.1002/ccr3.6330. eCollection 2022 Sep.
7
A Rare Case Report of Intra-abdominal Mucormycosis Complicating Acute Pancreatitis.
Indian J Crit Care Med. 2022 Jun;26(6):736-738. doi: 10.5005/jp-journals-10071-24232.
8
Gastrointestinal mucormycosis: A periodic systematic review of case reports from 2015 to 2021.
Microb Pathog. 2022 Feb;163:105388. doi: 10.1016/j.micpath.2022.105388. Epub 2022 Jan 4.
9
Gastric mucormycosis with splenic invasion a rare abdominal complication of COVID-19 pneumonia.
J Clin Imaging Sci. 2021 Nov 17;11:62. doi: 10.25259/JCIS_161_2021. eCollection 2021.
10
Fungal Taxa Responsible for Mucormycosis/"Black Fungus" among COVID-19 Patients in India.
J Fungi (Basel). 2021 Aug 7;7(8):641. doi: 10.3390/jof7080641.
Zotero 插件